Match Document Document Title
US20120003304 Solid Forms  
The present invention is directed to a solid form comprising an active ingredient and croscarmellose, wherein: (i) the croscarmellose has a median particle size of ≧56 microns, (ii) the...
US20140227351 TASTE MASKED PHARMACEUTICAL COMPOSITION  
Taste masked multi-layered particles include an inert core, one or more coating layer(s) comprising a pharmaceutically active ingredient and a binder, an intermediate coating layer (seal coating)...
US20120082718 Morphine Formulations  
Described is a pellet composition comprising a core element comprising morphine sulfate, a filler and a binder, wherein the morphine sulfate, calculated as the anhydrous form, comprises about 50...
US20100272792 STABILITY ADDITIVES FOR DRY DHA DOSAGE FORMS  
The use of additives to stabilize DHA when compressed into tablets, or filled as a powder into capsules, for oral administration.
US20130337052 System and Method of Reducing Impairment of Alertness, Concentration, Motivation, and Creativity Caused by Medication  
Administering a therapeutically effective dose of lithium ions mitigates the side effects of a psychoactive substance such as a cannabinoid. The therapeutically effective dose of lithium ions...
US20130315989 METHOD FOR TREATING A PATIENT VIA PHOTODYNAMIC THERAPY COMPRISING A MACROMOLECULAR CAPSULE  
A composition for photodynamic therapy including a polymer capsule having a diameter of about 10 nm to about 2000 nm synthesized by copolymerization of a flat aromatic compound represented by...
US20120282331 MAMMALIAN METABOLITES OF STEROIDS  
Described herein, in certain embodiments, are steroidal derivatives, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using...
US20140004183 METHODS FOR TREATING CARDIOVASCULAR DISEASE IN STATIN-TOLERANT SUBJECTS  
In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease in a statin-intolerant subject in need thereof and, in particular, a...
US20090053304 Composition and method of producing a taste masking formulation of laxatives for bowel cleaning preparation prior to colonoscopy  
This invention relates to a solid taste masking formulation of laxatives which can be dispersed in water for oral use for bowel cleaning preparation prior to colonoscopy procedures. This invention...
US20110064803 NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING VITAMIN K2  
The present invention is directed to compositions comprising a nanoparticulate vitamin K2 having improved bioavailability. The nanoparticulate vitamin K2 particles of the composition have an...
US20130344140 NOVEL PHARMACEUTICAL COMBINATIONS AND METHODS FOR TREATING CANCER  
Methods of selectively targeting a p53-deficient cancer cell, comprising administering to a patient suffering from cancer (i) a reversible cell cycle arrest-inducing agent for inducing cell cycle...
US20140227330 CAPSULE WHOSE ENVELOPE IS SEPARATELY IMPERCEPTIBLE DURING THE TOPICAL USE THEREOF  
A capsule for cosmetic and/or dermatological ingredients and processes for the production thereof. The capsule comprises an envelope which is solid, semisolid and/or dimensionally stable and...
US20140271833 INJECTION-MOLDED DOSAGE FORM  
An injection-molded shell of a dosage form of good quality is producible by a) providing a composition comprising i) from 25 to 90 weight percent of ethylcellulose, ii) from 7.5 to 60 weight...
US20050152966 Delivery system for biological component  
A controlled release delivery system composition and method for oral administration of a biological component is disclosed. Preferably, a bacterium is delivered, and more preferably the bacterium...
US20140271832 RACECADOTRIL LIPID COMPOSITIONS  
A composition comprising racecadotril, at least one surfactant and a lipid.
US20140212483 Compositions for Treatment of Attention Deficit Hyperactivity Disorder  
Therapeutic compositions and methods for treatment of attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) include dosage forms that deliver a therapeutic amount of...
US20120156277 ABUSE RESISTANT DRUGS, METHOD OF USE AND METHOD OF MAKING  
An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier...
US20110076325 ABUSE RESISTANT DRUGS, METHOD OF USE AND METHOD OF MAKING  
An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier...
US20110002985 ABUSE RESISTANT DRUGS, METHOD OF USE AND METHOD OF MAKING  
An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier...
US20140127289 LOW ERUCTATION COMPOSITION AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE IN A SUBJECT WITH FISH ALLERGY/HYPERSENSITIVITY  
In various embodiments, the present invention provides pharmaceutical compositions comprising fatty acids and methods for treating subjects using same.
US20130302414 SOLUBILIZED CAPSULE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE  
The present disclosure includes various embodiments directed to a solubilized capsule formulation of asunaprevir,...
US20060147515 Bioactive dispersible formulation  
A composition containing an effective amount of a water-insoluble bioactive agent and two surfactants having different HLB values, the difference between the HLB values of the two surfactants...
US20140227197 Compositions for Treatment of Attention Deficit Hyperactivity Disorder  
Therapeutic compositions and methods for treatment of attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) include dosage forms that deliver a therapeutic amount of...
US20120114748 Tanaproget Compositions Containing Ethinyl Estradiol  
Compositions containing micronized tanaproget, or a pharmaceutically acceptable salt thereof, and ethinyl estradiol and methods of preparing the same are provided. Also provided are kits...
US20140348912 CAPSULE FOR ENCAPSULATING A TABLET  
A capsule for encapsulating a tablet, includes two capsule portions of equal sizes and dimensions, each containing a moisture content of 12 to 16% and having a plurality of ridges projecting...
US20070275053 Anti-stick formula delivered by spray process to facilitate swallowing of solid object, such as pill, tablet capsule or caplet.  
An oral delivery method and composition that will facilitate the swallowing of any object such as a pill, tablet, capsule or caplet in a fast, easy, untroubled manner so as to markedly decrease...
US20140294949 VERMIN POISON  
Use of an orally or nasally available formulation of Tretazicar for poisoning vermin. An orally available or nasally available formulation of Tretazicar, wherein in the orally available...
US20110091535 SOLID PHARMACEUTICAL FORMULATION  
The present invention relates to a sustained-release solid pharmaceutical formulation comprising (a) an active medical ingredient, (b) a pre-gelatinized starch in an amount of 10 to 90% by weight...
US20120231073 DEXLANSOPRAZOLE COMPOSITIONS  
Premixes of dexlansoprazole with pharmaceutical excipients, processes for preparing premixes, pharmaceutical formulations containing the premixes, and their use in treatment of erosive esophagitis...
US20150202167 Trans-Clomiphene Formulations and Uses Thereof  
The present invention provides iraws-clomiphene and pharmaceutically acceptable salts and solvates thereof, characterized in that trans-clomiphene is in particulate form having a specific size...
US20110189271 PHARMACEUTICAL FORMULATIONS OF ACID-LABILE DRUGS  
Pharmaceutical formulations comprising inert cores that are coated with a layer comprising an amorphous dexlansoprazole sodium salt formed in-situ, further sequentially coated with an intermediate...
US20070207215 Medicament On The Basis Of Honey, Preparation And Use Thereof  
Honey is treated thermally At 100-160° and the obtained solution is settled. Then the solution is mixed with adsorbent and again settled, further it is filtered. The obtained filtrate represents a...
US20050281872 Enhanced compliance antiviral medicaments and methods of manufacture and use  
Reduced gastrointestinal side effect medicaments for treating viral infection in a patient suffering therefrom are provided comprising at least 500 mg of antiviral compound in an oral dosage form...
US20060292213 Enoximone formulations and their use in the treatment of PDE-III mediated diseases  
The present invention provides pharmaceutical formulations of the drug enoximone for use in treatment of disease states in which inhibition of PDE-III may be beneficial.
US20110182984 High Content Sodium Ibuprofen Granules, Their Preparation And Their Use In Preparing Non-Effervescent Solid Dosage Forms  
Granules of racemic sodium ibuprofen dihydrate formed from components specified herein have very desirable properties and can be effectively used in conventional rotary press tableting equipment...
US20110052680 ENCAPSULATION OF OXIDATIVELY UNSTABLE COMPOUNDS  
An encapsulated material containing an oxidation-sensitive core is covered by at least a dried phospholipid layer, and contains at least one phytosterol in the core, the phospholipid layer or in a...
US20060153900 Dietary supplement for treatment of lipid risk factors  
A dietary supplement is provided for the treatment of lipid risk factors comprising nicotinic acid, pantethine and lemon/orange flavonates. This supplement provides significant benefit in affect...
US20080057114 Sinker capsules  
Sinker Capsules are gelatin capsules with two halves that are filled with a dense material, such as chocolate or other similiar material, in one half and medication in the other half. The bottonm...
US20110014131 NANOMOLDING MICRON AND NANO SCALE FEATURES  
Small scale and nanoscopic identification features can be fabricated for pharmaceutical capsules. A composition comprising a capsule component, wherein the capsule component comprises a gelled...
US20140004184 COATED TABLET FORMULATIONS AND USES THEREOF  
The present invention provides coated tablet formulations comprising neratinib maleate, and improved methods for making such coated tablets.
US20110150988 DIETARY SUPPLEMENT COMPOSITION FOR BLOOD LIPID HEALTH  
A human or animal dietary supplement composition comprising one or more long chain (C24-C36) primary alcohols (policosanols) dispersed in food-grade oils or fats where the policosanol particle...
US20140356289 Multisomes: Encapsulated Droplet Networks  
The invention provides a droplet encapsulate comprising: a drop of a hydrophobic medium; a peripheral layer of non-polymeric amphipathic molecules around the surface of the drop; and an aqueous...
US20110195101 Polysaccharide Capsules and Methods of Preparation  
The present invention is directed to seamless capsules and methods for making seamless capsules having a high oil content as described herein. More specifically, the present invention is directed...
US20060292195 Tooth drops  
Tooth cleaning drops with an outer shell defining an inner chamber filled with a tooth cleaning substance. The outer shell may be made of the same material as the tooth cleaning substance. The...
US20140308212 EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF DISEASE  
Compositions comprising a therapeutic agent encapsulated by an edible plant-derived microvesicle are provided. Methods of treating an inflammatory disorder and methods of treating a cancer are...
US20110123614 Oral Dosage Forms for Delivery of Therapeutic Agents  
Oral dosage forms for the delivery of therapeutic agents include mechanical fasteners for engaging tissue of the gastrointestinal tract.
US20110318410 RARE EARTH METAL COMPOUNDS, METHODS OF MAKING, AND METHODS OF USING THE SAME  
Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the...
US20120258169 Chewable Soft Capsule  
A matrix formulation for a soft chewable capsule is provided which includes a gel-forming composition, a plasticizer, a polymer modifier, and water. The polymer modifier may be a carboxylic acid...
US20110059165 SEAMLESS ALGINATE CAPSULES  
The present invention is directed to a dried seamless capsule comprising an alginate shell membrane encapsulating fill material, wherein: (i) said alginate shell membrane comprises a polyvalent...
US20100021536 ENHANCED-DIFFUSION CAPSULE  
An ingestible capsule is provided for delivering medication to a subject. A capsule coating dissolves in a gastrointestinal tract of the subject. An inner core of the capsule has an outer surface...